| 摘要: |
| ［摘要］ 急性冠脉综合征（acute coronary syndromes ACS）是冠心病(coronary hear disease,CHD)致死和致残的主要原因之一。近年来的研究使人们对ACS从概念更新到深入认识，随着CHD药物治疗的进展和急诊技术的成熟和广泛开展,ACS的治疗效果和预后显著改善。该文对ACS的最新进展作一综述。 |
| 关键词: 急性冠脉综合征 药物治疗 再灌注治疗 |
| DOI：10.3969/j.issn.1674-3806.2010.07.39 |
| 分类号:R 541.4 |
| 基金项目: |
|
| New research progress of accutecoronary syndrome |
|
LI Xing-yang,RAO Shao-lai
|
|
Department of Cardiology,Chongzuo People′s Hospital,Guangxi 532200,China
|
| Abstract: |
| ［Abstract］ Acute coronary syndrome(ACS) is one of main cause of the mortality and morbidity in coronary heart disease.Recently, with the progress of pharmacotherapy and widely application of primary percutanous coronary intervention in the treatment of coronary heart disese,the treatment effectiveness and prognosis of ACS have been improved significantly.This article reviews the new research progress of ACS. |
| Key words: Acute coronary syndrome Drug therapy Reperfusion therapy |
